Historic Perspective and Future Directions.- Preparation, Image Acquisition and Post-Processing.- Contrast Media for CT Examination.- Normal Coronary Anatomy.- Coronary Artery Stenosis.- Post-PCI Follow Up.- Post-CABG Follow.- Atherosclerotic Plaques and Asymptomatic Disease.- Coronary Calcification.- Coronary Artery Anomalies.- Congenital Heart Disease.- Imaging Diseases of Aorta.- Imaging Peripheral Vasculature INCLUDING CAROTIDS.- EP Applications – Coronary Veins and Pulmonary Veins.- Intracardiac, Myocardial and Extracardiac Abnormalities.- CT for Myocardial Function and Perfusion Alone or in Combination with SPECT and PET.- Role in Emergency Department.- Incidental Findings During Coronary CT Angiography.- Role of CT in Cardiology Practice.
Matthew Budoff is an expert on coronary artery calcification (CAC)
and CT angiography. He is recognized as a leader in the development
of CAC Scoring and an innovator in the non-invasive objective
detection methods for cardiac disease. He is an investigator in
many large pharmaceutical trials and multicenter studies funded by
the National Institutes of Health.
Dr. Budoff’s research is devoted to advancing procedures that can
help doctors identify patients early that are at high-risk for
cardiac events and progression of coronary calcium. This early
detection can lead to patients being placed on the correct
therapeutic path to prevent a heart attack. Additionally, Dr.
Budoff’s research focuses on how to maximize the utility of
non-contrast CT scans of the heart. His team has shown that
supplementary measurements can be evaluated for thoracic aortic
calcification, aortic valve calcification, mitral annular
calcification, pericardial fat, liver fat, myocardial scar and bone
density.
Stephan Achenbach is the Chairman of Cardiology and a Professor of
Medicine at the University of Erlangen, Germany. His research
interests focus on cardiovascular imaging, mainly computed
tomography, for the early detection and characterization of
coronary atherosclerosis and for the support of coronary and
cardiovascular interventional procedures.
Dr. Achenbach was the Founding President of the SCCT from
2005-2007, and served as a Vice President of the ESC for the
2014-2016 period. He is currently a Board Member of ESC and Chair
of the Congress Program Committee and serves as the Editor-in-Chief
of the Journal of Cardiovascular Computed Tomography.
Dr. Achenbach has received several awards, including the Jan Brod
Award for Clinical Research of the Medical School of Hannover,
Germany (1999), the Thomas C. Cesario Distinguished Visiting
Professorship Award from the University of California Irvine School
of Medicine (2007), the Simon Dack Award from the American College
of Cardiology (2009), the Gold Medal of the Society of
Cardiovascular Computed Tomography (2015), as well as the Sir
Godfrey Hounsfield Memorial Award of the British Institute of
Radiology (2016).
Harvey S. Hecht is an internationally recognized expert in cardiac
imaging and preventive cardiology, and is the author of more than
100 publications in peer reviewed journals. After achieving acclaim
as a leader in the fields of nuclear cardiology and stress
echocardiography, Dr. Hecht pioneered the development of
noninvasive coronary computed tomographic angiography (CTA) and is
a driving force behind CTA guided percutaneous coronary
intervention and the relationship between CTA and intravascular
ultrasound (IVUS). He was the first to demonstrate the poor
relationship between risk factors and atherosclerosis.
Jagat Narula is Professor of Medicine and Philip J. and Harriet L.
Goodhart Chair in Cardiology, and the Director of Cardiovascular
Imaging Program in Mount Sinai’s Zena and Michael A. Wiener
Cardiovascular Institute and the Marie-Josée and Henry R. Kravis
Center for Cardiovascular Health. He is the Associate Dean for
Global Health at the Icahn School of Medicine at Mount Sinai.
Dr. Narula has specifically contributed to two major areas
including heart muscle cell apoptosis in heart failure, and
lipid-rich atherosclerotic plaques that are susceptible to rupture
and acute coronary events. He has brought novel experimental
strategies to bedside and defined their applicability at the
community level. He has served on the Advisory Council on Global
Prevention of Cardiovascular Diseases of the Institute of Medicine
of the National Academies of Sciences.
Ask a Question About this Product More... |